Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05177952 · ClinicalTrials.gov registry record · NA
Low-Load Blood Flow Restriction on Patients With Multiple Sclerosis
A NA study, sponsored by University of Central Florida.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05177952 is a NA study that has completed, run by University of Central Florida. The registered enrollment target is 20 participants.
The verdict
NCT05177952, a NA study, has completed, sponsored by University of Central Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This research is being done to compare the current standard of care for strength training for patients with Multiple Sclerosis to lightweight resistance training with blood flow restriction.
Interventions
- OTHER Standard of Care
- OTHER Blood Flow Restriction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2024-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05177952
The ClinicalTrials.gov registry entry for NCT05177952 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT05177952 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05177952 about?
NCT05177952 is a clinical study titled "Low-Load Blood Flow Restriction on Patients With Multiple Sclerosis". This research is being done to compare the current standard of care for strength training for patients with Multiple Sclerosis to lightweight resistance training with blood flow restriction.
What is the current status of trial NCT05177952?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2022-01-01. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT05177952?
The interventions under investigation include: Standard of Care (OTHER), Blood Flow Restriction (OTHER).
Who is sponsoring clinical trial NCT05177952?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.